[go: up one dir, main page]

MX2014008693A - Administracion transdermica de hormonas. - Google Patents

Administracion transdermica de hormonas.

Info

Publication number
MX2014008693A
MX2014008693A MX2014008693A MX2014008693A MX2014008693A MX 2014008693 A MX2014008693 A MX 2014008693A MX 2014008693 A MX2014008693 A MX 2014008693A MX 2014008693 A MX2014008693 A MX 2014008693A MX 2014008693 A MX2014008693 A MX 2014008693A
Authority
MX
Mexico
Prior art keywords
transdermal hormone
hormone delivery
delivery
compositions
transdermal
Prior art date
Application number
MX2014008693A
Other languages
English (en)
Inventor
Agis Kydonieus
Thomas M Rossi
Charles G Arnold
Ajay K Banga
Vishal Sachdeva
Original Assignee
Agile Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agile Therapeutics Inc filed Critical Agile Therapeutics Inc
Publication of MX2014008693A publication Critical patent/MX2014008693A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen composiciones y dispositivos para la administración transdérmica de hormonas. Las composiciones y dispositivos incluyen desogestrel y permiten la administración de cantidades eficaces de progestina sin el uso de potenciadores de permeación en la piel.
MX2014008693A 2012-01-27 2013-01-25 Administracion transdermica de hormonas. MX2014008693A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261591533P 2012-01-27 2012-01-27
US201261702304P 2012-09-18 2012-09-18
PCT/US2013/023105 WO2013112806A2 (en) 2012-01-27 2013-01-25 Transdermal hormone delivery

Publications (1)

Publication Number Publication Date
MX2014008693A true MX2014008693A (es) 2014-08-27

Family

ID=48741464

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014008693A MX2014008693A (es) 2012-01-27 2013-01-25 Administracion transdermica de hormonas.

Country Status (11)

Country Link
US (2) US20130195956A1 (es)
EP (1) EP2806862A2 (es)
JP (1) JP6345120B2 (es)
AU (1) AU2013212005A1 (es)
BR (1) BR112014018426A8 (es)
CA (1) CA2861324A1 (es)
HK (1) HK1204287A1 (es)
MX (1) MX2014008693A (es)
NZ (1) NZ627242A (es)
WO (1) WO2013112806A2 (es)
ZA (1) ZA201405249B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017024783A2 (pt) 2015-05-18 2018-08-07 Agile Therapeutics Inc composições contraceptivas e métodos para eficácia melhorada e modulação dos efeitos colaterais
US10835499B2 (en) 2015-12-30 2020-11-17 Corium, Inc. Systems and methods for long term transdermal administration
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
JP2020511463A (ja) 2017-03-15 2020-04-16 アジル・セラピューティクス・インコーポレイテッドＡｇｉｌｅ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 個別化避妊製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
US5558071A (en) * 1994-03-07 1996-09-24 Combustion Electromagnetics, Inc. Ignition system power converter and controller
US7384650B2 (en) 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US7045145B1 (en) 1999-11-24 2006-05-16 Agile Therapeutics, Inc. Transdermal contraceptive delivery system and process
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
CN1487836A (zh) * 2000-03-14 2004-04-07 埃米林药品公司 胰高糖素样肽1(7-36)对胃窦幽门十二指肠能动性的影响
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
MXPA06006682A (es) * 2003-12-12 2006-08-11 Schering Ag Hormonas de administracion transdermica que no necesitan potenciadores de penetracion.
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US20060057186A1 (en) * 2004-09-11 2006-03-16 Margaret Heller Oral contraceptive multivitamin compound and methods of administration
AU2007302586B2 (en) * 2006-09-25 2013-06-27 Archer-Daniels-Midland Company Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same
EP2167001A4 (en) 2007-07-10 2012-10-31 Agile Therapeutics Inc DEVICE FOR THE DERIVED ULTRASONIC WELDING
AU2008275101B2 (en) 2007-07-10 2014-08-21 Agile Therapeutics, Inc. Dermal delivery device with in situ seal
US20130084243A1 (en) * 2010-01-27 2013-04-04 Liliane Goetsch Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
JP5670335B2 (ja) * 2008-09-25 2015-02-18 セファロン、インク． ベンダムスチン液体製剤
US20110028412A1 (en) * 2009-08-03 2011-02-03 Cappellos, Inc. Herbal enhanced analgesic formulations

Also Published As

Publication number Publication date
HK1204287A1 (en) 2015-11-13
CA2861324A1 (en) 2013-08-01
EP2806862A2 (en) 2014-12-03
ZA201405249B (en) 2016-07-27
BR112014018426A2 (es) 2017-06-20
JP2015508750A (ja) 2015-03-23
BR112014018426A8 (pt) 2017-07-11
US20180078493A1 (en) 2018-03-22
US20130195956A1 (en) 2013-08-01
WO2013112806A3 (en) 2013-11-21
NZ627242A (en) 2016-08-26
JP6345120B2 (ja) 2018-06-20
WO2013112806A2 (en) 2013-08-01
AU2013212005A1 (en) 2014-07-31

Similar Documents

Publication Publication Date Title
PH12014502095A1 (en) Estrogen receptor modulators and uses thereof
PH12015501737A1 (en) Androgen receptor modulators and uses thereof
PH12015502621A1 (en) Estrogen receptor modulator and uses thereof
PH12014501351B1 (en) Fluorinated estrogen receptor modulators and uses thereof
MX2015011132A (es) Moduladores policiclicos del receptor de estrogenos y sus usos.
MX2015016171A (es) Moduladores del receptor de estrogeno de azetidina y usos de los mismos.
PH12013500481A1 (en) Estrogen receptor modulators and uses thereof
PH12012502419A1 (en) Estrogen receptor modulators and uses thereof
PH12014501000A1 (en) Dermal delivery compositions and methods
IL253123A0 (en) Preparations for administration through the skin and their uses
PH12015500115B1 (en) Glucagon analogues
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
BR112014031824A2 (pt) terapias de reposição hormonal transdérmica
EP3054932A4 (en) Dexmedetomidine transdermal delivery devices and methods for using the same
MX2015008021A (es) Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos.
MD20170048A2 (ro) Formulare pe bază de acetat de abirateronă şi procedee de utilizare a acesteia
MX2014010537A (es) Moduladores de receptor x del higado (lxr) para el tratamiento de enfermedades, trastornos y condiciones dermicas.
EP3054931A4 (en) Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions
BR112015030387A2 (pt) compostos de pirazol como moduladores de fshr e usos dos mesmos
EP3131524A4 (en) Methods and compositions for topical delivery for skin care
MX339196B (es) Composiciones de aripiprazol y metodos para su suministro transdermico.
EP3019130A4 (en) DRUG-PROLONGED TRANSDERMAL RELEASE KIT USING LIQUID OR SEMI-SOLID COMPOSITIONS AND METHOD OF USING THE SAME
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
MX2014008693A (es) Administracion transdermica de hormonas.
PH12014501573A1 (en) Topical pharmaceutical compositions comprising bexarotene and a corticosteroids